Proposed clinical indicators for efficient screening and testing for COVID-19 infection using Classification and Regression Trees (CART) analysis
- PMID: 33079625
- PMCID: PMC8023244
- DOI: 10.1080/21645515.2020.1822135
Proposed clinical indicators for efficient screening and testing for COVID-19 infection using Classification and Regression Trees (CART) analysis
Abstract
The introduction and rapid transmission of SARS-CoV-2 in the United States resulted in methods to assess, mitigate, and contain the resulting COVID-19 disease derived from limited knowledge. Screening for testing has been based on symptoms typically observed in inpatients, yet outpatient symptoms may differ. Classification and regression trees recursive partitioning created a decision tree classifying participants into laboratory-confirmed cases and non-cases. Demographic and symptom data from patients ages 18-87 years enrolled from March 29-June 8, 2020 were included. Presence or absence of SARS-CoV-2 was the target variable. Of 832 tested, 77 (9.3%) tested positive. Cases significantly more often reported diarrhea (12 percentage points (PP)), fever (15 PP), nausea/vomiting (9 PP), loss of taste/smell (52 PP), and contact with a COVID-19 case (54 PP), but less frequently reported sore throat (-27 PP). The 4-terminal node optimal tree had sensitivity of 69%, specificity of 78%, positive predictive value of 20%, negative predictive value of 97%, and AUC of 76%. Among those referred for testing, negative responses to two questions could classify about half (49%) of tested persons with low risk for SARS-CoV-2 and would save limited testing resources. Outpatient symptoms of COVID-19 appear to be broader than the inpatient syndrome.Initial supplies of anticipated COVID-19 vaccines may be limited and administration of first such available vaccines may need to be prioritized for essential workers, the most vulnerable, or those likely to have a robust response to vaccine. Another priority group could be those not previously infected. Those who screen out of testing may be less likely to have been infected by SARS-CoV-2 virus thus may be prioritized for vaccination when supplies are limited.
Keywords: COVID-19; SARS-CoV-2; classification trees; screening; symptoms.
Figures
Update of
-
Proposed Clinical Indicators for Efficient Screening and Testing for COVID-19 Infection from Classification and Regression Trees (CART) Analysis.medRxiv [Preprint]. 2020 May 14:2020.05.11.20097980. doi: 10.1101/2020.05.11.20097980. medRxiv. 2020. Update in: Hum Vaccin Immunother. 2021 Apr 3;17(4):1109-1112. doi: 10.1080/21645515.2020.1822135. PMID: 32511556 Free PMC article. Updated. Preprint.
References
-
- Ihle-Hansen H, Berge T, Tveita A, Rønning EJ, Ernø PE, Andersen EL, Wang CH, Tveit A, Myrstad M.. COVID-19: symptoms, course of illness and use of clinical scoring systems for the first 42 patients admitted to a Norwegian local hospital. Tidsskr Nor Laegeforen. 2020. doi: 10.4045/tidsskr.20.0301. - DOI - PubMed
-
- Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases (NCIRD) Division of Viral Diseases . Symptoms of coronavirus. [accessed 2020 May 31].https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html.
-
- Lu X, Wang L, Sakthivel SK, Whitaker B, Murray J, Kamili S, Lynch B, Malapati L, Burke SA, Harcourt J. US CDC real-time reverse transcription pcr panel for detection of severe acute respiratory syndrome coronavirus 2. Emerging Infect Dis. 2020;26(8):8. doi: 10.3201/eid2608.201246. - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous